Cancer

May 21, 2020

Researchers writing in JAMA Dermatology this week report that patients with inflammatory bowel disease, rheumatoid arthritis, and psoriasis who are treated with biologics may have a "clinically meaningful" increase in melanoma risk, but the jury is still out.

February 20, 2020

A double-blind, placebo-controlled, randomized clinical trial has confirmed that low-dose methotrexate is associated with an increased risk of skin cancer, according to a study published this week in the Annals of Internal Medicine.

February 20, 2020

A systematic review and meta-analysis published today in JAMA Dermatology confirms that psoriasis patients have a slightly increased risk of cancer, specifically, keratinocyte cancer and lymphomas.

May 02, 2019

French researchers writing in Arthritis and Rheumatology describe a biomarker that may determine the risk of mortality in patients with dermatomyositis who develop cancer, a common outcome in adults.

January 27, 2017

Rheumatologists are likely to encounter a wide variety of immune-related adverse events as use of immune checkpoint inhibitors expands.